Bosley Katrine 4
4 · Editas Medicine, Inc. · Filed Jun 5, 2018
Insider Transaction Report
Form 4
Bosley Katrine
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2018-06-01$39.15/sh−800$31,320→ 1,293,932 total - Sale
Common Stock
2018-06-01$37.81/sh−1,019$38,528→ 1,294,732 total - Sale
Common Stock
2018-06-01$39.96/sh−300$11,988→ 1,293,632 total - Sale
Common Stock
2018-06-01$37.18/sh−6,214$231,037→ 1,295,751 total
Footnotes (5)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $36.67 to $37.62. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $37.67 to $38.15. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $38.76 to $39.54. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $39.785 to $40.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.